RAIMONDO, ANNUNZIATA
 Distribuzione geografica
Continente #
NA - Nord America 785
EU - Europa 401
AS - Asia 89
AF - Africa 3
Totale 1.278
Nazione #
US - Stati Uniti d'America 784
IT - Italia 253
IE - Irlanda 60
CN - Cina 49
SE - Svezia 27
DE - Germania 15
VN - Vietnam 14
IN - India 10
FR - Francia 9
UA - Ucraina 9
FI - Finlandia 8
GB - Regno Unito 6
TR - Turchia 5
CH - Svizzera 4
HK - Hong Kong 4
JP - Giappone 4
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GR - Grecia 1
IS - Islanda 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
RO - Romania 1
SG - Singapore 1
SI - Slovenia 1
Totale 1.278
Città #
Chandler 231
Princeton 149
Dublin 58
Ann Arbor 52
Salerno 34
Wilmington 34
Naples 24
Ashburn 21
Beijing 19
Andover 17
Houston 16
Milan 16
Seattle 15
Dong Ket 14
Jacksonville 14
Rome 14
Woodbridge 12
Boardman 9
Pune 9
Albignasego 8
West Jordan 8
Guangzhou 7
Lamezia Terme 6
Napoli 6
Izmir 5
Lappeenranta 5
Nanjing 5
Redwood City 5
Aversa 4
Bari 4
Bernezzo 4
Fisciano 4
Florence 4
Norwalk 4
Tokyo 4
Asti 3
Fairfield 3
Helsinki 3
London 3
Marano Vicentino 3
Marcianise 3
Mercato San Severino 3
Padova 3
Paris 3
Pavia 3
Pellezzano 3
Sarno 3
Settimo Torinese 3
Torre del Greco 3
Turin 3
Afragola 2
Agropoli 2
Altopascio 2
Aprilia 2
Bedizzole 2
Cairo 2
Catania 2
Cerignola 2
Cornebarrieu 2
Esslingen am Neckar 2
Forino 2
Frankfurt am Main 2
Fremont 2
Fréjus 2
Gaiarine 2
Genoa 2
Lecco 2
Mariano Comense 2
Marseille 2
Mendrisio 2
Montelupone 2
Montesarchio 2
Munich 2
Nembro 2
Nocera Superiore 2
Pagani 2
Pomigliano d'Arco 2
Rimini 2
Santa Giusta 2
Selargius 2
Taranto 2
Venice 2
Verona 2
Washington 2
Zagreb 2
Abidjan 1
Agios Stefanos 1
Atlanta 1
Basel 1
Brno 1
Brooklyn 1
Cambridge 1
Campoformido 1
Carpegna 1
Castano Primo 1
Changsha 1
Copenhagen 1
Crystal Springs 1
Edinburgh 1
Freiburg im Breisgau 1
Totale 971
Nome #
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 89
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 84
Interleukin-33: increasing role in dermatological conditions 57
IL-33 is regulated by TNF-α in normal and psoriatic skin 41
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 35
European Task Force on Contact Dermatitis statement on coronavirus disease-19 (COVID-19) outbreak and the risk of adverse cutaneous reactions 34
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 31
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 30
IL-26 in allergic contact dermatitis: Resource in a state of readiness 29
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 29
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 28
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 28
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 28
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 28
Atopic dermatitis: Epidemiology and clinical phenotypes 28
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 25
IL-26: A new actor in allergic contact dermatitis 25
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 24
The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa 24
A journey into psoriasis: From the adipose tissue to the skin 24
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 24
Guselkumab for the treatment of psoriasis 23
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 23
Flash-pumped pulsed dye laser for vascular skin lesions: our experience and an overview of the literature 23
UVB-induced p53 is reduced by a mixture of natural extracts 23
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 23
Human Microbiome: Composition and Role in Inflammatory Skin Diseases 22
Photosensitivity and cancer immune-targeted therapies 21
Clinical predictors of psoriatic arthritis and osteoclast differentiation 21
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 20
RAST: Clinical applications 20
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 20
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 19
A potential prognostic test for bone erosion development in patients with cutaneous predictive sites for psoriatic arthritis 19
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 19
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 18
The laboratory role in the assessment of sensitization and irritation potential of cosmetics 18
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 17
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 17
Psoriasis, cardiovascular events, and biologics: Lights and shadows 15
New insights into mechanism of Notch signaling in hidradenitis suppurativa 14
The role of the dermatologist in the immune-mediated/allergic diseases – position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum 14
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 13
Systemic inflammation: psoriasis as a model…in Naples 13
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 12
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 11
Letters to the editor 11
Guselkumab e psoriasi in sedi difficili: efficacia ed impatto sulla qualità di vita in pazienti naive o bio experienced 10
Limitations of current monoclonal antibodies for plaque-type psoriasis and an outlook for the future 10
Photodermatoses and Skin Cancer 10
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review 9
Notch dysregulation and hidradenitis suppurativa, psoriasis, atopic dermatitis and lichen planus: let's talk about Numb 9
Ultrasonography in the management of a recurrent and eruptive lobular capillary hemangioma and resolution with intense pulsed light 9
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 9
Novel interactions among ultraviolet B, skin and adipose tissue 9
Psoriasi eritrodermica: rapida efficacia di bimekizumab 8
Psoriasi e terapia con guselkumab: panoramica 2022 dal centro prescrittore AOU Salerno 8
Polymorphic light eruption: What's new in pathogenesis and management 8
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection 8
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 7
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 7
Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: A cross-sectional study in Italy 6
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 4
Studio osservazionale descrittivo per la valutazione della prevalenza della psoriasi nei pazienti adulti dislipidemici in terapia monoclonale con anti-PCSK9 4
Dermatite atopica e stress ossidativo: nuovi biomarker 4
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 2
Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy 2
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 1
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 1
Totale 1.359
Categoria #
all - tutte 6.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 1 5 0
2019/202024 10 0 4 0 0 0 0 0 1 2 6 1
2020/202175 0 0 3 0 11 7 19 0 1 10 8 16
2021/2022255 2 4 3 20 30 2 0 11 21 5 40 117
2022/2023544 55 56 27 74 27 102 6 53 87 15 27 15
2023/2024366 23 54 39 26 35 45 28 46 18 52 0 0
Totale 1.359